Britain’s Health Secretary Sajid Javid is self-isolating after testing positive for COVID-19. In a statement posted on Twitter, Javid said he was awaiting the result of a full PCR test and had only mild symptoms. “This morning I tested positive for COVID. I’m waiting for my PCR result, but thankfully I have had my jabs…
AstraZeneca’s $39 Billion Deal To Buy Alexion Given All-Clear
Coronavirus vaccine maker AstraZeneca has been given the all-clear by the UK competition watchdog to go ahead with its $39 billion (£28.2 billion) megadeal to buy U.S. drug company Alexion Pharmaceuticals. The Competition and Markets Authority (CMA) said it had decided not to refer the acquisition for an in-depth investigation, paving the way for the…
Australian Government’s Vaccination Commercial Meets With Heavy Public Backlash
The federal government’s $41 million (US$ 30.7 million) nationwide “Arm Yourself” campaign, to encourage Australians to get vaccinated with a COVID-19 jab has come under intense criticism after members of the public took to the social media platform Twitter to vent their frustration. The 30-second commercial, which aired on Sydney television on Sunday, features a young…
Fourth Australian Dies From Blood-Clots After Receiving AstraZeneca Vaccine
A 72-year-old woman has died after developing rare blood clots following the AstraZeneca jab. The South Australian woman received the vaccine on June 24, became unwell and was admitted to the Royal Adelaide Hospital on July 5. She passed away on July 11, according to State Premier Steven Marshall. “Our thoughts are with her family…
Pfizer Shots Could Be Available to Australians Under-40 in September
Pfizer vaccines could be available to Australians under 40 as early as September or October, the head of the COVID-19 vaccine task force said on Tuesday. Lieutenant-General John Frewen told reporters that currently, there was a limited amount of imported Pfizer vaccines and an abundance of locally-made AstraZeneca. Therefore the current age group priorities would…
The Reasons Why Australians Are Slow to Take up the Vaccine
Commentary Last week, my octogenarian parents received their second AstraZeneca (AZ) vaccine jab and were shocked to find that they were among the exclusive six percent Australian club of those fully vaccinated against COVID-19. They were told this figure by their GP, who commented that this was an extremely low figure and congratulated them on…
Why Australians Are Slow To Take Up the Vaccine
Commentary Last week, my octogenarian parents received their second AstraZeneca (AZ) vaccine jab and were shocked to find that they were among the exclusive six percent Australian club of those fully vaccinated against COVID-19. They were told this figure by their GP, who commented that this was an extremely low figure and congratulated them on…
Heath Canada Adds Warning of Very Rare, Serious Condition as Potential Side Effect
OTTAWA—Health Canada is updating the label for the Oxford-AstraZeneca and COVISHIELD COVID-19 vaccines to add capillary leak syndrome as a potential side-effect. The agency is also including a warning for patients with a history of the ailment to not get those vaccines. Capillary leak syndrome is a very rare, serious condition that causes fluid leakage…
Health Canada Adds Warning of Very Rare, Serious Condition as Potential Side Effect
OTTAWA—Health Canada is updating the label for the Oxford-AstraZeneca and COVISHIELD COVID-19 vaccines to add capillary leak syndrome as a potential side-effect. The agency is also including a warning for patients with a history of the ailment to not get those vaccines. Capillary leak syndrome is a very rare, serious condition that causes fluid leakage…
Delayed Second Shot and Third ‘Booster’ of AstraZeneca’s COVID Vaccine Offer Strong Immune Responses: Study
A new study into AstraZeneca’s COVID-19 vaccine shows that a second dose administered later than within the recommended 4–12 week period after the first one offered greater protection, while a third dose led to a further increase in immune response and protection against viral variants, offering both greater flexibility in vaccination schedules and showing promise…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`